Literature DB >> 4598241

Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP; NSC-107392), with special reference to its iron-chelating properties.

I H Krakoff, E Etcubanas, C Tan, K Mayer, V Bethune, J H Burchenal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598241

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  5 in total

1.  Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.

Authors:  Erika M Becker; David B Lovejoy; Judith M Greer; Ralph Watts; Des R Richardson
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Authors:  Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  J Inorg Biochem       Date:  2007-10-30       Impact factor: 4.155

3.  Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study.

Authors:  Enrico Baruffini; Roberta Ruotolo; Franco Bisceglie; Serena Montalbano; Simone Ottonello; Giorgio Pelosi; Annamaria Buschini; Tiziana Lodi
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

4.  Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.

Authors:  Karla Pelivan; Lisa M Frensemeier; Uwe Karst; Gunda Koellensperger; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Anal Bioanal Chem       Date:  2018-02-23       Impact factor: 4.142

5.  Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition.

Authors:  Iuliana Besleaga; Iryna Stepanenko; Tatsiana V Petrasheuskaya; Denisa Darvasiova; Martin Breza; Marta Hammerstad; Małgorzata A Marć; Alexander Prado-Roller; Gabriella Spengler; Ana Popović-Bijelić; Eva A Enyedy; Peter Rapta; Anatoly D Shutalev; Vladimir B Arion
Journal:  Inorg Chem       Date:  2021-07-19       Impact factor: 5.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.